# Biomerica Inc: filings

BMRA · Nasdaq · CIK 73290 · [Healthcare](/sectors/healthcare.md) · fiscal year ends May 31

Pages: [Overview](/companies/bmra.md) · [Financials](/companies/bmra/financials.md) · [Filings](/companies/bmra/filings.md) · [Insiders](/companies/bmra/insiders.md)

## Reports and events: 162 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 173, 8-K 64, 10-Q 54, 10-K 18, DEF 14A 18, SC 13G/A 12, 3 9, 4/A 9, SC 13G 9, 424B5 7, CORRESP 7, S-8 7, UPLOAD 6, EFFECT 5, S-3 5, 5 4, 10-K/A 3, 10-Q/A 2, NT 10-Q 2, PRE 14A 2, 5/A 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, D 1, DEFA14A 1, NT 10-K 1, S-3/A 1, SC 13D 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 21:00 ET | [DEF 14A](/filings/0001493152-26-047438.md) | Proxy statement, period 2026-10-16 | 0001493152-26-047438 |
| 2026-10-15 | 21:00 ET | [10-Q](/filings/0001493152-26-047271.md) | Quarterly report, period 2026-08-31 | 0001493152-26-047271 |
| 2026-10-15 | 21:00 ET | [8-K](/filings/0001493152-26-047270.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-047270 |
| 2026-09-28 | 21:00 ET | [10-K/A](/filings/0001493152-26-044621.md) | Annual report, amended, period 2026-05-31 | 0001493152-26-044621 |
| 2026-08-31 | 21:00 ET | [10-K](/filings/0001493152-26-040851.md) | Annual report, period 2026-05-31 | 0001493152-26-040851 |
| 2026-08-28 | 21:20 ET | [SCHEDULE 13D](/filings/0001213900-26-095193.md) | Ownership report, active investor | 0001213900-26-095193 |
| 2026-08-26 | 20:54 ET | [8-K](/filings/0001493152-26-040251.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-040251 |
| 2026-06-04 | 20:45 ET | [8-K](/filings/0001493152-26-027290.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-027290 |
| 2026-04-13 | 21:15 ET | [10-Q](/filings/0001493152-26-016388.md) | Quarterly report, period 2026-02-28 | 0001493152-26-016388 |
| 2026-01-14 | 22:15 ET | [10-Q](/filings/0001493152-26-002286.md) | Quarterly report, period 2025-11-30 | 0001493152-26-002286 |
| 2025-12-16 | 13:19 ET | [8-K](/filings/0001493152-25-027891.md) | 5.07 Shareholder vote results | 0001493152-25-027891 |
| 2025-10-20 | 21:05 ET | [DEF 14A](/filings/0001493152-25-018668.md) | Proxy statement, period 2025-12-12 | 0001493152-25-018668 |
| 2025-10-14 | 21:11 ET | [10-Q](/filings/0001493152-25-018043.md) | Quarterly report, period 2025-08-31 | 0001493152-25-018043 |
| 2025-10-08 | 12:19 ET | [8-K](/filings/0001493152-25-017363.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-017363 |
| 2025-09-26 | 21:16 ET | [10-K/A](/filings/0001493152-25-015785.md) | Annual report, amended, period 2025-05-31 | 0001493152-25-015785 |
| 2025-08-29 | 21:10 ET | [10-K](/filings/0001641172-25-026041.md) | Annual report, period 2025-05-31 | 0001641172-25-026041 |
| 2025-06-06 | 13:29 ET | [8-K](/filings/0001641172-25-013942.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013942 |
| 2025-04-16 | 13:00 ET | [8-K](/filings/0001641172-25-004976.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-004976 |
| 2025-04-14 | 20:15 ET | [10-Q](/filings/0001641172-25-004571.md) | Quarterly report, period 2025-02-28 | 0001641172-25-004571 |
| 2025-01-14 | 22:06 ET | [10-Q](/filings/0001493152-25-002209.md) | Quarterly report, period 2024-11-30 | 0001493152-25-002209 |
| 2024-12-17 | 22:00 ET | [8-K](/filings/0001493152-24-050432.md) | 5.07 Shareholder vote results | 0001493152-24-050432 |
| 2024-11-06 | 22:20 ET | [8-K](/filings/0001493152-24-043867.md) | 3.01 Delisting notice | 0001493152-24-043867 |
| 2024-10-15 | 21:00 ET | [10-Q](/filings/0001493152-24-041156.md) | Quarterly report, period 2024-08-31 | 0001493152-24-041156 |
| 2024-09-30 | 21:00 ET | [DEF 14A](/filings/0001493152-24-038820.md) | Proxy statement, period 2024-09-30 | 0001493152-24-038820 |
| 2024-08-28 | 21:00 ET | [10-K](/filings/0001493152-24-034208.md) | Annual report, period 2024-05-31 | 0001493152-24-034208 |
| 2024-06-28 | 21:15 ET | [8-K](/filings/0001493152-24-025656.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-025656 |
| 2024-05-10 | 21:15 ET | [8-K](/filings/0001493152-24-018697.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-018697 |
| 2024-04-12 | 21:00 ET | [10-Q](/filings/0001493152-24-014474.md) | Quarterly report, period 2024-02-29 | 0001493152-24-014474 |
| 2024-01-16 | 12:00 ET | [10-Q](/filings/0001493152-24-002331.md) | Quarterly report, period 2023-11-30 | 0001493152-24-002331 |
| 2023-12-11 | 22:19 ET | [8-K](/filings/0001493152-23-044431.md) | 5.07 Shareholder vote results | 0001493152-23-044431 |
| 2023-10-12 | 21:15 ET | [10-Q](/filings/0001493152-23-037070.md) | Quarterly report, period 2023-08-31 | 0001493152-23-037070 |
| 2023-09-27 | 21:15 ET | [DEF 14A](/filings/0001493152-23-034447.md) | Proxy statement, period 2023-09-27 | 0001493152-23-034447 |
| 2023-09-19 | 17:20 ET | [8-K](/filings/0001493152-23-033030.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-033030 |
| 2023-08-28 | 12:10 ET | [8-K](/filings/0001493152-23-030303.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-030303 |
| 2023-08-25 | 21:00 ET | [10-K](/filings/0001493152-23-030254.md) | Annual report, period 2023-05-31 | 0001493152-23-030254 |
| 2023-07-26 | 20:46 ET | [8-K](/filings/0001513162-23-000117.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001513162-23-000117 |
| 2023-04-25 | 13:10 ET | [8-K](/filings/0001513162-23-000074.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-23-000074 |
| 2023-04-14 | 20:48 ET | [10-Q](/filings/0001513162-23-000067.md) | Quarterly report, period 2023-02-28 | 0001513162-23-000067 |
| 2023-03-07 | 21:46 ET | [8-K](/filings/0001513162-23-000034.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-23-000034 |
| 2023-03-02 | 14:23 ET | [8-K](/filings/0001513162-23-000023.md) | 5.02 Departure or appointment of officers or directors | 0001513162-23-000023 |
| 2023-02-07 | 14:14 ET | [8-K](/filings/0001513162-23-000015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-23-000015 |
| 2023-01-13 | 21:55 ET | [10-Q](/filings/0001513162-23-000005.md) | Quarterly report, period 2022-11-30 | 0001513162-23-000005 |
| 2022-12-29 | 21:28 ET | [8-K/A](/filings/0001513162-22-000153.md) | 5.07 Shareholder vote results | 0001513162-22-000153 |
| 2022-12-16 | 21:35 ET | [8-K](/filings/0001513162-22-000148.md) | 5.02 Departure or appointment of officers or directors | 0001513162-22-000148 |
| 2022-12-16 | 21:20 ET | [8-K](/filings/0001513162-22-000147.md) | 5.02 Departure or appointment of officers or directors | 0001513162-22-000147 |
| 2022-12-09 | 21:07 ET | [8-K](/filings/0001513162-22-000140.md) | 5.07 Shareholder vote results | 0001513162-22-000140 |
| 2022-12-09 | 21:01 ET | [8-K](/filings/0001513162-22-000139.md) | 5.02 Departure or appointment of officers or directors | 0001513162-22-000139 |
| 2022-11-14 | 14:00 ET | [8-K](/filings/0001513162-22-000131.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001513162-22-000131 |
| 2022-10-13 | 20:12 ET | [10-Q](/filings/0001513162-22-000122.md) | Quarterly report, period 2022-08-31 | 0001513162-22-000122 |
| 2022-09-27 | 20:00 ET | [DEF 14A](/filings/0001513162-22-000119.md) | Proxy statement, period 2022-12-07 | 0001513162-22-000119 |

Page 1 of 4. [Older](/companies/bmra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:53 ET. No prices; not investment advice.